Arrowstreet Capital
TMCI icon

Arrowstreet Capital’s Treace Medical Concepts TMCI Stock Holding History

Arrowstreet Capital’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-21,711
Closed -$547K – 1475
2023
Q1 		$547K Buy
+21,711
New +$510K ﹤0.01% 1163

Other funds holding TMCI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Arrowstreet Capital's TMCI Position: Q2 2023 in Review

Arrowstreet Capital sold out of Treace Medical Concepts (TMCI) in Q2 2023, closing a stake of 21,711 shares — an estimated $547K sold.

Arrowstreet Capital first reported a position in TMCI in Q1 2023 and held it in 1 quarter. The position peaked at $547K in Q1 2023. 137 funds tracked by Wall St. Rank hold TMCI as of Q2 2023.

  • Arrowstreet Capital reported no remaining Treace Medical Concepts position as of Q2 2023 after selling out during the quarter.
  • Arrowstreet Capital sold 21,711 Treace Medical Concepts shares in Q2 2023, an estimated $547K.
  • Arrowstreet Capital first reported a position in Treace Medical Concepts in Q1 2023 and held it in 1 quarter.
  • Arrowstreet Capital's Treace Medical Concepts position peaked at $547K in Q1 2023.
  • 137 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2023.

Based on Arrowstreet Capital's 13F filing for Q2 2023, filed 14 Aug 2023.